Kimberly Grande, MD
Dermatology · Knoxville, TNNPI 1073666335
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $141,212 of the $223,985 with a category attached, or 63.0%. 38 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 54.6% of the total. Among dermatology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,367 payments — averaging $163.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$122K
- UCB, Inc.$31K
- AbbVie$19K
- Pfizer$10K
- Aclaris Therapeutics, Inc.$9K
- Johnson & Johnson$8K
- plus $25K from 32 others
Across 78 payments — averaging $8090.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aclaris Therapeutics, Inc.$253K
- E.r. Squibb & Sons, L.L.C.$142K
- Amgen$81K
- Eli Lilly$55K
- LEO Pharma AS$48K
- Bausch Health US, LLC$40K
- plus $13K from 2 others
What the payments were for
- Consulting fees$23,62811%
- Speaking & faculty fees$141,21263%
- Travel & lodging$30,98914%
- Food & beverage$27,57112%
- Education$5860%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$223,985 in reported general payments places this provider in the 95th percentile of 209 dermatology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 14 | $95,753 |
| Fluorouracil | 106 | $7,093 |
| Fluocinonide | 68 | $2,312 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 68 | $2,057 |
| Doxycycline Hyclate | 66 | $2,018 |
| Ketoconazole | 80 | $1,344 |
| Triamcinolone Acetonide | 188 | $1,214 |
| Clobetasol Propionate | 20 | $1,074 |
| Metronidazole | 18 | $1,030 |
| Mometasone Furoate | 58 | $922 |
| ValacyclovirValacyclovir Hcl | 32 | $681 |
| Clindamycin Phosphate | 18 | $613 |
| Mupirocin | 62 | $477 |
| Hydrocortisone | 78 | $373 |
| Minocycline Hcl | 26 | $343 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Knoxville
- Matthew DoppeltKnoxville$36K
- Carley FowlerKnoxville$27K
- Meredith OverholtKnoxville$21K
- Robert GriffithKnoxville$14K
- Robert GriffithKnoxville$14K
- Brittany WareKnoxville$10K
- Elizabeth AndersonKnoxville$8K
- Lee DittrichKnoxville$8K
- Kimberly VincentNashville$1.5M
- Adrian RodriguezNashville$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.